In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results

The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE

NeoepitopesFLLLPQLHC        Click here to BLAST against human proteome
CTL Epitope
HLA I Alleles
(ProPred I)
HLA-A*0201, HLA-A*0205, HLA-A2.1, HLA-A3, HLA-B*51, HLA-B*5401, HLA-B627
HLA I Alleles
HLA II Alleles
DRB1_0101, DRB1_0102, DRB1_0305, DRB1_0401, DRB1_0408, DRB1_0426, DRB1_0801, DRB1_0802, DRB1_0813, DRB1_0817, DRB1_1101, DRB1_1104, DRB1_1106, DRB1_1114, DRB1_1120, DRB1_1128, DRB1_1302, DRB1_1305, DRB1_1307, DRB1_1311, DRB1_1321, DRB1_1323, DRB1_150223

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package